Financials
- Market Capitalization 137.3 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
28.93
Fiyat/satışlar oranı
10.13
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 208 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 794.19 USD | -1.67% | -4.83% | +13.46% | +36.80% | 81.77 B USD | ||
| 263 | ARGX argenx SE - American Depositary Shares | 1023.21 USD | -3.37% | -0.01% | +18.84% | +43.71% | 63.32 B USD | ||
| 296 | MRNA Moderna, Inc. - Common Stock | 137.99 USD | -3.35% | -3.30% | +146.94% | +476.64% | 55.09 B USD | ||
| 351 | RVMD Revolution Medicines, Inc. - Common Stock | 207.88 USD | -6.00% | -0.57% | +13.25% | +275.23% | 44.56 B USD |